Can you drill down into the results of LEADER, including primary end points and breakdown of MACE events? What did we learn about the dose of liraglutide required for CV outcome improvement?

Can you drill down into the results of LEADER, including primary end points and breakdown of MACE events? What did we learn about the dose of liraglutide required for CV outcome improvement?

Can you drill down into the results of LEADER, including primary end points and breakdown of MACE events? What did we learn about the dose of liraglutide required for CV outcome improvement?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Vivian Fonseca, MD

Vivian Fonseca, MD

Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Past President, Science and Medicine
American Diabetes Association